Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
GSK has announced $100 million of new investment in its manufacturing site in Montana to expand production capacity of key components of the adjuvant system used in several of GSK's vaccines.
read more
Wednesday, March 17, 2021
CGT Catapult announced GSK will leverage the CGT Catapult Stevenage facility to perform GMP cell processing to accelerate its cell and gene therapy pipeline for clinical trials.
read more
Monday, December 28, 2015
GlaxoSmithKline has announced the completion of its transaction to divest its rights to ofatumumab for auto-immune indications to Novartis Pharma AG, a subsidiary of Novartis AG, following regulatory approval.
read more
Friday, September 27, 2019
GlaxoSmithKline (GSK) has completed a $120 million expansion of its manufacturing site in the Philadelphia suburb of Upper Merion, PA.
read more
Guadalupe, Nuevo León, Grupo Yacana México S.A.S de C.V. is voluntarily recalling All Lots of Yacana Hand Sanitizer, 70% Alcohol, 250 ml to the consumer level.
read more
Monday, December 12, 2016
Grünenthal Group has entered into a definitive agreement with Astellas Pharma Europe Ltd., the European subsidiary of Tokyo-based Astellas Pharma Inc., for the exclusive rights to the dermal patch Qutenza® (capsaicin 8%) in Europe, Middle East and ...
read more
Wednesday, February 25, 2015
The lack of biosimilars in the growth hormone deficiency (GHD) treatment pipeline does not signify a missed opportunity, because superior products exist in the form of next-generation biologics known as biobetters, says an analyst with research and ...
read more
Groupe PARIMA, a Quebec-based CDMO specializing in non-sterile liquid, suspension, semi-solid and spray drug products, has joined the Pharma & Biopharma Outsourcing Association (PBOA), the trade association for CMOs and CDMOs, as a General Member.
read more
Wednesday, January 20, 2021
Gritstone has obtained a nonexclusive license to Genevant’s LNP technology to develop and commercialize SAM vaccines against SARS-CoV-2.
read more
Grifols announced that it has restated its 2005 agreement with OraSure Technologies. Additionally, Grifols is building a biological manufacturing facility in the San Francisco Bay Area.
read more
Thursday, February 04, 2016
Greenphire, a global clinical payment technology company, has announced unprecedented year over year growth as a result of demand for its technology solutions from sponsors, CROs, universities, and hospitals looking to automate their payment ...
read more
Greenphire’s Patient Experience Dataset establishes the industry’s first repository of global patient-level insights by phase, therapeutic area, and country, including average stipends (where permitted) and reimbursements by categorical expense, ...
read more
Greenphire, a provider of global clinical payment solutions, has appointed Wayne Baker as Chief Commercial Officer to lead the commercial strategy of the rapidly growing organization worldwide.
read more
Monday, February 05, 2024
Greenphire, a provider of software solutions for streamlining clinical trials, announced the acquisition of Clincierge, a provider of concierge travel and logistics support for patients participating in clinical trials.
read more
GreenLight Biosciences and Samsung Bio announced the successful completion of their first commercial-scale mRNA engineering run.
read more